☰

Vera Huang, Ph.D. - Publications

Affiliations: 
2007 Biology University of California, San Diego, La Jolla, CA 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Reich SH, Sprengeler PA, Chiang GG, Appleman JR, Chen J, Clarine J, Eam B, Ernst JT, Han Q, Goel VK, Han EZ, Huang V, Hung IN, Jemison A, Jessen KA, et al. Structure-based Design of Pyridone-aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition. Journal of Medicinal Chemistry. PMID 29526098 DOI: 10.1021/Acs.Jmedchem.7B01795  0.357
2017 Huang V. Endogenous miRNAa: miRNA-Mediated Gene Upregulation. Advances in Experimental Medicine and Biology. 983: 65-79. PMID 28639192 DOI: 10.1007/978-981-10-4310-9_5  0.484
2017 Webster KR, Goel VK, Staunton J, Hung IN, Parker GS, Stumpf CR, Molter J, Chiang GG, Wegerski CJ, Sperry S, Chen J, Huang V, Thompson PA, Tran C, Ernst JT, et al. Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade Cancer Research. 77. DOI: 10.1158/1538-7445.Transcontrol16-Pr11  0.407
2017 Webster KR, Goel VK, Staunton J, Stumpf CR, Sharma R, Hung IN, Parker GS, Molter J, Chiang GG, Wegerski CJ, Sperry S, Huang V, Chen J, Thompson PA, Tran C, et al. Abstract 596: eFT508, a potent and highly selective inhibitor of MNK1/2 regulates immune checkpoint and cytokine expression promoting anti-tumor immunity Cancer Research. 77: 596-596. DOI: 10.1158/1538-7445.Am2017-596  0.413
2015 Wang J, Place RF, Portnoy V, Huang V, Kang MR, Kosaka M, Ho MK, Li LC. Inducing gene expression by targeting promoter sequences using small activating RNAs. Journal of Biological Methods. 2. PMID 25839046 DOI: 10.14440/jbm.2015.39  0.396
2015 Wang J, Huang V, Ye L, Bárcena A, Lin G, Lue TF, Li LC. Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells and Development. 24: 345-53. PMID 25232932 DOI: 10.1089/Scd.2014.0290  0.465
2015 Webster KR, Goel VK, Hung IN, Parker GS, Staunton J, Neal M, Molter J, Chiang GG, Jessen KA, Wegerski CJ, Sperry S, Huang V, Chen J, Thompson PA, Appleman JR, et al. eFT508, a Potent and Selective Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 Inhibitor, Is Efficacious in Preclinical Models of Diffuse Large B-Cell Lymphoma (DLBCL) Blood. 126: 1554-1554. DOI: 10.1182/Blood.V126.23.1554.1554  0.421
2014 Guo D, Barry L, Lin SS, Huang V, Li LC. RNAa in action: from the exception to the norm. Rna Biology. 11: 1221-5. PMID 25602906 DOI: 10.4161/15476286.2014.972853  0.494
2014 Huang V, Li LC. Demystifying the nuclear function of Argonaute proteins. Rna Biology. 11: 18-24. PMID 24384674 DOI: 10.4161/Rna.27604  0.458
2013 Huang V, Zheng J, Qi Z, Wang J, Place RF, Yu J, Li H, Li LC. Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. Plos Genetics. 9: e1003821. PMID 24086155 DOI: 10.1371/Journal.Pgen.1003821  0.466
2013 Ren S, Kang MR, Wang J, Huang V, Place RF, Sun Y, Li LC. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. The Prostate. 73: 1591-601. PMID 23836514 DOI: 10.1002/Pros.22709  0.485
2012 Place RF, Wang J, Noonan EJ, Meyers R, Manoharan M, Charisse K, Duncan R, Huang V, Wang X, Li LC. Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Molecular Therapy. Nucleic Acids. 1: e15. PMID 23343884 DOI: 10.1038/Mtna.2012.5  0.485
2012 Wang X, Wang J, Huang V, Place RF, Li LC. Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. The Biochemical Journal. 443: 821-8. PMID 22339500 DOI: 10.1042/Bj20111491  0.471
2012 Huang V, Li LC. miRNA goes nuclear. Rna Biology. 9: 269-73. PMID 22336708 DOI: 10.4161/Rna.19354  0.347
2012 Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li LC. Upregulation of Cyclin B1 by miRNA and its implications in cancer Nucleic Acids Research. 40: 1695-1707. PMID 22053081 DOI: 10.1093/Nar/Gkr934  0.349
2011 Portnoy V, Huang V, Place RF, Li LC. Small RNA and transcriptional upregulation. Wiley Interdisciplinary Reviews. Rna. 2: 748-60. PMID 21823233 DOI: 10.1002/Wrna.90  0.475
2010 Wang J, Place RF, Huang V, Wang X, Noonan EJ, Magyar CE, Huang J, Li LC. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Research. 70: 10182-91. PMID 21159640 DOI: 10.1158/0008-5472.Can-10-2414  0.342
2010 Huang V, Qin Y, Wang J, Wang X, Place RF, Lin G, Lue TF, Li LC. RNAa is conserved in mammalian cells. Plos One. 5: e8848. PMID 20107511 DOI: 10.1371/Journal.Pone.0008848  0.443
2009 Huang V, Lu X, Jiang Y, Wang JY. Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73. Bmc Biology. 7: 35. PMID 19558638 DOI: 10.1186/1741-7007-7-35  0.463
2004 Hybiske K, Ichikawa JK, Huang V, Lory SJ, Machen TE. Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cellular Microbiology. 6: 49-63. PMID 14678330 DOI: 10.1046/J.1462-5822.2003.00342.X  0.301
Show low-probability matches.